Aratana Therapeutics, Inc. (PETX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.30 / 7.16
Exchange NASDAQ
Div & Yield N.A. (N.A)
2 Promising Biopharmas Reach Key Junctures

2 Promising Biopharmas Reach Key Junctures

FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Aratana Therapeutics (PETX) Is Strong On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

2 Small-Cap Stocks That Could Win Big

2 Small-Cap Stocks That Could Win Big

Investing in small-cap names take a lot of research and patience, but they can also be very rewarding.

Aratana Therapeutics (PETX) Stock: Weak On High Volume Today

Aratana Therapeutics (PETX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a weak on high relative volume candidate

Aratana Therapeutics (PETX) Is Today's Strong On High Volume Stock

Aratana Therapeutics (PETX) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Aratana Therapeutics (PETX) Stock Jumps Ahead of Drug Data Presentation

Aratana Therapeutics (PETX) Stock Jumps Ahead of Drug Data Presentation

Aratana Therapeutics (PETX) stock is spiking on Thursday afternoon as the pet therapeutics company said it will present pivotal efficacy and safety data about its galliprant tablets for dogs.

First Week of November 18th Options Trading For Aratana Therapeutics (PETX)

First Week of November 18th Options Trading For Aratana Therapeutics (PETX)

Investors in Aratana Therapeutics, Inc saw new options begin trading this week, for the November 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Strong On High Relative Volume: Aratana Therapeutics (PETX)

Strong On High Relative Volume: Aratana Therapeutics (PETX)

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

8 Stocks Under $10 to Trade for Big Gains

8 Stocks Under $10 to Trade for Big Gains

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 Making Big Breakout Moves

7 Stocks Under $10 Making Big Breakout Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

8 Stocks Under $10 Making Big Moves Higher

8 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Insider Trading Alert - UTX, CFR And PETX Traded By Insiders

Insider Trading Alert - UTX, CFR And PETX Traded By Insiders

Stocks with insider trader activity include UTX, CFR and PETX

Relative Strength Alert For Aratana Therapeutics

Relative Strength Alert For Aratana Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are poised to move higher from current levels.

Trade-Ideas: Aratana Therapeutics (PETX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Aratana Therapeutics (PETX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Aratana Therapeutics Enters Oversold Territory (PETX)

Aratana Therapeutics Enters Oversold Territory (PETX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Under $10 to Trade for Big Breakouts

5 Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades and moving much higher from current levels.

Insider Trading Alert - PETX, PANW And OFG Traded By Insiders

Insider Trading Alert - PETX, PANW And OFG Traded By Insiders

Stocks with insider trader activity include PETX, PANW and OFG

Trade-Ideas: Aratana Therapeutics (PETX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Aratana Therapeutics (PETX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a strong on high relative volume candidate

Market News: Nike, Pier 1 Imports, Aratana Therapeutics

Market News: Nike, Pier 1 Imports, Aratana Therapeutics

The stock markets in the United States declined except the Dow Jones Industrial Average, up by 0.61% as of 2:41 in the afternoon in New York today. The biotechnology shares slid toward a bear market, ...

Aratana Therapeutics Enters Oversold Territory

Aratana Therapeutics Enters Oversold Territory

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Aratana Therapeutics (PETX) Highlighted As Weak On High Volume

Aratana Therapeutics (PETX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a weak on high relative volume candidate

Commit To Purchase Aratana Therapeutics At $15, Earn 14.4% Annualized Using Options

Commit To Purchase Aratana Therapeutics At $15, Earn 14.4% Annualized Using Options

Investors eyeing a purchase of Aratana Therapeutics, Inc shares, but cautious about paying the going market price of $18.69/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2016 put at the $15 strike, which has a bid at the time of this writing of $1.00.

Aratana Therapeutics (PETX) Is Weak On High Volume Today

Aratana Therapeutics (PETX) Is Weak On High Volume Today

Trade-Ideas LLC identified Aratana Therapeutics (PETX) as a weak on high relative volume candidate

Animal Health Partner, Aratana Therapeutics, Announces Positive Pivotal Results For Controlling Postsurgical Pain In Dogs

Animal Health Partner, Aratana Therapeutics, Announces Positive Pivotal Results For Controlling Postsurgical Pain In Dogs

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) announced today that Aratana Therapeutics, Inc.

4 Big-Volume Stocks to Trade for Breakouts

4 Big-Volume Stocks to Trade for Breakouts

These stocks rising on unusual volume could be within range of triggering breakout trades.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCOR, CALD, CVI, FE, HNH, HPY, HY, ICAD, JKS, LSG, OPHC, POPE, RDHL, RXN, SEAS, TDS, VGR, VOYA Downgrades: APOL, AWI, DBD, ETH, FLS, GCA, JMP, MGI, MYE, NFG, OMI, PETX, ROVI, SPWR, TUES, UTHR Initiations: BCRH, HAWKB Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHT, GLOG, TREE Downgrades: AMOV, AMX, CAPL, CKP, CUZ, ENPH, LYV, OGE Initiations: PETX, VRNS Read on to get TheStreet Quant Ratings' detailed report:

Commit To Buy Aratana Therapeutics At $12.50, Earn 9.7% Annualized Using Options

Commit To Buy Aratana Therapeutics At $12.50, Earn 9.7% Annualized Using Options

Investors eyeing a purchase of Aratana Therapeutics, Inc shares, but tentative about paying the going market price of $19.20/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $12.50 strike, which has a bid at the time of this writing of 55 cents.